CLINICAL_TRIALS
trial_result
· 2017-04-25
Clinical Trial Update: BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in Subjects With Pre-Diabetes [Phase 2]
Summary
Phase 2 clinical trial evaluating BTI320 (SUGARDOWN) for reducing post-prandial hyperglycemia in people with prediabetes; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese University of Hong Kong | Conditions: Pre-Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2017-04-25